ArticleMolecular endocrinology (Baltimore, Md.)2011

CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer.

Renjini Ambika Padmanabhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.